Gabapentin Capsule
Product Images NDC 50090-7673

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 50090-7673). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 01)

A line graph depicting mean pain scores over 8 weeks for two groups: placebo and gabapentin 3600 mg/day. The x-axis represents weeks, including a 4-week dose titration period and a 4-week fixed dose period, while the y-axis shows mean pain scores from 0 to 10. Gabapentin group scores decrease over time, while placebo group scores remain relatively stable.*

FDA Label Image

Figure 2 (Image 02)

Line graph depicting mean pain scores over a 7-week period for placebo and two Gabapentin dosage groups (1800 mg/day and 2400 mg/day). The x-axis represents weeks, including a 3-week dose titration period and a 4-week fixed dose period, while the y-axis represents mean pain scores from 0 to 10.*

FDA Label Image

Figure 3 (Image 03)

A bar chart titled 'Figure 3. Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing placebo (PBO) and Gabapentin (GBP) groups in two studies. The vertical axis shows percent responders from 0% to 100%. Study 1 presents 12% for placebo and 29% for GBP 3600 mg. Study 2 shows 14% for placebo, 32% for GBP 1800 mg, and 34% for GBP 2400 mg. Statistical significance is indicated with p-values less than 0.01 and 0.001.*

FDA Label Image

Cockcroft And Gault Equation (Image 04)

A mathematical formula showing the calculation for creatinine clearance (CLCr) using age in years, weight in kilograms, serum creatinine in mg/dL, and a factor adjustment for female patients. The formula is presented clearly with variables and constants for clinical use.*

FDA Label Image

Gabapentin Structural Formula (Image 05)

Chemical structure diagram of Gabapentin, showing its molecular arrangement with a cyclohexane ring attached to an aminomethyl and a carboxymethyl group.*

FDA Label Image

Image-09 (Image 09)

A scatter plot chart showing difference percentages on the vertical axis and daily dose in milligrams on the horizontal axis. Data points represent results from three separate studies labeled 'study a,' 'study b,' and 'study c,' with daily doses ranging approximately from 600 mg to 1800 mg.*

FDA Label Image

Label Image (Lbl500907673)

Gabapentin 100 mg oral capsules in a white bottle label with black and red text. The label indicates 90 capsules per bottle, manufactured by A-S Medication Solutions, Libertyville, IL 60048. Storage instructions specify 68 to 77 degrees Fahrenheit. The label includes an NDC number 50090-7673-0 and a lot number S5734-0.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.